Publications by authors named "T J Nester"
Background: Volume-reduced platelets can minimize circulatory overload, allergic transfusion reactions, or out-of-group plasma infusion. Our center adopted a volume reduction protocol that includes acidification with acid citrate dextrose solution A (ACD-A) before centrifugation and without any rest period prior to resuspension allowing a better turnaround time for platelet issue.
Study Design And Methods: This report compares corrected count increments (CCIs) from full-volume and ACD-A acidified volume-reduced human platelets in a retrospective study at a single hospital and in a mouse model.
Article Synopsis
- A study tested plasma samples from 1596 donors who reported COVID-19 symptoms after donating blood for SARS-CoV-2 RNA and specific antibodies.* -
- Results showed that having prior infection or vaccination provided protection against developing SARS-CoV-2 RNAemia and symptomatic infection.* -
- The rates of RNAemia remained consistent regardless of whether the samples were taken during the Delta or Omicron variant phases.*
Utilization of a technology-assisted workflow to prepare controlled substance oral syringes.
Am J Health Syst Pharm
August 2023
Purpose: Utilization of technology-assisted workflow (TAWF) systems has gained popularity in the sterile compounding setting. This study was designed to evaluate whether safety and efficiency could be seen when preparing oral controlled substance doses gravimetrically vs volumetrically.
Methods: This 2-phase observational study combined manual data collection with automated logs generated by a single TAWF.
Background: The Spanish toothcarp (Aphanius iberus Valenciennes, 1846) is a small fish endemic to the eastern coastline of the Iberian Peninsula and is currently listed as "Endangered" (category IUCN: EN). It mainly inhabits brackish waters which can exhibit large fluctuations in temperature and salinity throughout the year. The genetics of A.
View Article and Find Full Text PDFArticle Synopsis
- * A study tested 2,250 blood donors who had possible COVID-19 symptoms after donation, finding that the presence of SARS-CoV-2 RNA peaked at 9%-15% in late 2020, dropping to about 4% after vaccinations were released.
- * Although RNA was detectable in some donors, no infectious virus was found in their plasma, indicating that blood transfusions are very unlikely to transmit SARS-CoV-2.